DarioHealth GAAP EPS of -$0.08 beats by $0.48, revenue of $6.26M misses by $1.66M

• DarioHealth press release (NASDAQ:DRIO): Q2 GAAP EPS of -$0.08 beats by $0.48.
• Revenue of $6.26M (+1.8% Y/Y) misses by $1.66M.
• Q2 revenue of $6.26 million reflects an increase of 8.6% over Q1 2024, and an increase of 1.7% over Q2 of 2023, driven primarily by increased B2B2C revenues
• Company expects to reach cashflow breakeven by the end of 2025
• Ended Q2 2024 with cash equivalents of $22.9 million

More on DarioHealth

• DarioHealth Corp. (DRIO) Q1 2024 Earnings Call Transcript
• DarioHealth reports Q1 results
• Seeking Alpha’s Quant Rating on DarioHealth
• Historical earnings data for DarioHealth
• Financial information for DarioHealth